Case Study: Merck

Merck is a global organization focused on developing new therapies that treat and prevent disease to helping people in need, committed to improving health and well-being around the world. To differentiate themselves in the diabetes marketspace Healthy Interactions worked with Merck to develop and launch a national diabetes education program. The program has been running in the United States for eight years.

Highlights of the U.S. Diabetes Program

• Collaboration with Merck to support their entrance into the diabetes market and launch of Januvia
• Developed in collaboration with and endorsed by the American Diabetes Association
• Worked with key opinion leaders, including patient advocate
• Initial research and design process to create prototype took 3 months
• Patient testing and refinement took another 3 months
• Support medical legal reviews and management within ZINC system
• Over 8 years in market with 28,000-plus HCPs trained
• Brand team, sales force, and customer solutions involved in program
• Program has expanded from original design to include many other tools and training

Proven Patient Results

A summary of 33 independent global studies support the impact of the Conversation Map methodology

• Return-to-session: 48% of the Conversation Map group returned for additional sessions vs. only 11% in the traditional care groups
• Enjoyment/Satisfaction: 97% of Conversation Map group enjoyed the sessions vs. 57% in traditional care groups
• Knowledge/Learning: 91% of Conversation Map group felt that they had improved their understanding vs. 52% in the traditional care groups